🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

159,76 USD

Máx. histórico

185,50

98 días

Caída desde máximo

-13,88%

Rango 52 semanas

122,14 – 186,12

Variación hoy

-3,79%

Cierre anterior

166,05

Rango de hoy

159,53 – 167,68

Volumen hoy

1.482.485

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
23,70 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 19 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/01/2001 35,14 36,50 33,00 33,94 -5,57% 9,96% 184.400
29/01/2001 33,25 35,94 32,25 35,94 +4,17% 11,09% 171.000
26/01/2001 33,31 34,69 32,44 34,50 +3,08% 6,75% 92.000
25/01/2001 33,00 33,63 31,69 33,47 -1,56% 5,87% 106.400
24/01/2001 31,94 34,13 30,81 34,00 +6,88% 10,37% 144.300
23/01/2001 28,98 31,88 28,38 31,81 +9,70% 12,08% 181.500
22/01/2001 31,38 32,56 28,50 29,00 -7,75% 12,95% 155.600
19/01/2001 32,25 32,75 31,25 31,44 -2,52% 4,65% 80.500
18/01/2001 30,31 32,44 29,75 32,25 +5,31% 8,87% 82.500
17/01/2001 35,58 36,25 29,88 30,63 -13,88% 17,92% 268.600
16/01/2001 30,69 36,00 29,94 35,56 +16,06% 19,76% 315.400
12/01/2001 29,38 31,00 27,63 30,64 +1,50% 11,49% 175.500
11/01/2001 28,38 30,88 28,38 30,19 +4,09% 8,81% 106.500
10/01/2001 26,00 29,00 25,94 29,00 +8,41% 11,78% 69.800
09/01/2001 25,31 27,50 24,50 26,75 +9,46% 11,85% 123.800
08/01/2001 24,75 27,13 23,88 24,44 -2,01% 13,13% 434.900
05/01/2001 29,00 29,02 23,38 24,94 -18,07% 19,45% 508.000
04/01/2001 31,00 33,06 30,44 30,44 -8,50% 8,47% 131.600
03/01/2001 31,38 35,25 31,38 33,27 +3,35% 12,35% 308.800
02/01/2001 33,48 33,63 31,63 32,19 -2,83% 5,97% 228.400
29/12/2000 35,13 35,50 32,19 33,13 -8,46% 9,43% 151.200
28/12/2000 34,50 36,38 33,63 36,19 +3,39% 7,97% 130.900
27/12/2000 31,63 35,00 31,63 35,00 +7,69% 10,67% 129.300
26/12/2000 30,88 32,75 30,75 32,50 +1,17% 6,48% 132.400
22/12/2000 32,00 32,63 30,56 32,13 +4,26% 6,45% 107.700
21/12/2000 29,25 31,75 28,00 30,81 +5,34% 12,82% 242.600
20/12/2000 28,41 29,69 27,50 29,25 -7,51% 7,70% 168.700
19/12/2000 32,06 33,75 31,50 31,63 -0,39% 7,02% 224.800
18/12/2000 31,50 33,13 31,06 31,75 +0,20% 6,55% 103.500
15/12/2000 30,38 33,00 29,50 31,69 +2,84% 11,52% 201.400